Article
Artemisinin partial resistance at a crossroads: evidence for continental variation in Plasmodium falciparum clearance phenotypes.
The Lancet. Infectious diseases - 1 Sept 2026
Hosangadi Varun, Fidock David A
Abstract excerpt
Artemisinin-based combination therapies (ACTs) remain the cornerstone of global malaria treatment, yet their long-term efficacy is threatened by the emergence of artemisinin partial resistance (ART-R). Current surveillance definitions rely on Plasmodium falciparum parasite clearance half-life thresholds derived from southeast Asia, where mutant kelch13 (k13)-mediated resistance produces prolonged parasite...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
